APPLIED GENETIC TECHNOLOGIES CORP Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q3 2017 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Applied Genetic Technologies Corp quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q3 2017 to Q3 2022.
  • Applied Genetic Technologies Corp Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2022 was -$304K, a 122% decline year-over-year.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$14K.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Investing Activities for 2021 was $38.1M, a 354% increase from 2020.
  • Applied Genetic Technologies Corp annual Net Cash Provided by (Used in) Investing Activities for 2020 was $8.4M, a 55.9% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$304K -$1.69M -122% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q3 2021 $1.39M -$4.86M -77.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q3 2020 $6.24M +$5.98M +2265% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q3 2019 $264K +$5.31M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q3 2018 -$5.05M -$31.7M -119% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q3 2017 $26.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.